{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:10:59Z","timestamp":1793459459043,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004948","name":"Astellas Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP17pc0101001"],"award-info":[{"award-number":["JP17pc0101001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.vaccine.2022.04.051","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T23:33:56Z","timestamp":1650929636000},"page":"3372-3379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Oral MucoRice-CTB vaccine is safe and immunogenic in healthy US adults"],"prefix":"10.1016","volume":"40","author":[{"given":"Yoshikazu","family":"Yuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Nojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotomi","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiho","family":"Kurokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Yamanoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rika","family":"Nakahashi-Ouchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Hiraizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohtaro","family":"Fujihashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kiyono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.vaccine.2022.04.051_b0005","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1016\/j.vaccine.2005.10.014","article-title":"A review of vaccine research and development: Human enteric infections","volume":"24","author":"Girard","year":"2006","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2022.04.051_b0010","doi-asserted-by":"crossref","first-page":"e0003832","DOI":"10.1371\/journal.pntd.0003832","article-title":"Updated global burden of cholera in endemic countries","volume":"9","author":"Ali","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"9835","key":"10.1016\/j.vaccine.2022.04.051_b0015","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1016\/S0140-6736(12)60436-X","article-title":"Cholera","volume":"379","author":"Harris","year":"2012","journal-title":"Cholera Lancet"},{"key":"10.1016\/j.vaccine.2022.04.051_b0020","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3390\/toxins7030974","article-title":"Cholera toxin B: One subunit with many pharmaceutical applications","volume":"7","author":"Baldauf","year":"2015","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.vaccine.2022.04.051_b0025","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.3390\/toxins2082132","article-title":"Toxin mediated diarrhea in the 21spi_supstspii_sup century: The pathophysiology of intestinal ion transport in the course of ETEC, V. Cholerae and rotavirus infection","volume":"2","author":"Kopic","year":"2010","journal-title":"Toxins (Basel)"},{"issue":"5790","key":"10.1016\/j.vaccine.2022.04.051_b0030","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/288499a0","article-title":"Amino acid sequence homology between cholera toxin and escherichia coli heat-labile toxin","volume":"288","author":"Dallas","year":"1980","journal-title":"Nature"},{"issue":"9404","key":"10.1016\/j.vaccine.2022.04.051_b0035","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0140-6736(03)15328-7","article-title":"Cholera (The Lancet)","volume":"363","author":"Sack","year":"2004","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.vaccine.2022.04.051_b0040","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1510330","article-title":"Efficacy of a Single-Dose, Inactivated Oral Cholera Vaccine in Bangladesh","volume":"374","author":"Qadri","year":"2016","journal-title":"N Engl J Med"},{"issue":"45","key":"10.1016\/j.vaccine.2022.04.051_b0045","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.1016\/j.vaccine.2018.09.026","article-title":"The Euvichol story \u2013 Development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships","volume":"36","author":"Odevall","year":"2018","journal-title":"Vaccine"},{"issue":"8499","key":"10.1016\/j.vaccine.2022.04.051_b0050","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(86)91944-6","article-title":"Field Trial of Oral Cholera Vaccines in Bangladesh","volume":"328","author":"Clemens","year":"1986","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2022.04.051_b0055","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/infdis\/158.2.372","article-title":"Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: Results of a large-scale field trial","volume":"158","author":"Clemens","year":"1988","journal-title":"J Infect Dis"},{"issue":"26","key":"10.1016\/j.vaccine.2022.04.051_b0060","doi-asserted-by":"crossref","first-page":"10986","DOI":"10.1073\/pnas.0703766104","article-title":"Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination","volume":"104","author":"Nochi","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"10.1016\/j.vaccine.2022.04.051_b0065","doi-asserted-by":"crossref","first-page":"8794","DOI":"10.1073\/pnas.0914121107","article-title":"Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine","volume":"107","author":"Tokuhara","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.vaccine.2022.04.051_b0070","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1021\/pr4002146","article-title":"MucoRice-cholera toxin B-subunit, a rice-based oral cholera vaccine, down-regulates the expression of \u03b1-amylase\/trypsin inhibitor-like protein family as major rice allergens","volume":"12","author":"Kurokawa","year":"2013","journal-title":"J Proteome Res"},{"issue":"1","key":"10.1016\/j.vaccine.2022.04.051_b0075","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11240-014-0575-4","article-title":"Determination of genomic location and structure of the transgenes in marker-free rice-based cholera vaccine by using whole genome resequencing approach","volume":"120","author":"Mejima","year":"2015","journal-title":"Plant Cell Tissue Organ Cult"},{"issue":"1","key":"10.1016\/j.vaccine.2022.04.051_b0080","doi-asserted-by":"crossref","DOI":"10.1186\/s12864-020-07355-7","article-title":"Comparative whole-genome and proteomics analyses of the next seed bank and the original master seed bank of MucoRice-CTB 51A line, a rice-based oral cholera vaccine","volume":"22","author":"Sasou","year":"2021","journal-title":"BMC Genomics"},{"issue":"10","key":"10.1016\/j.vaccine.2022.04.051_b0085","doi-asserted-by":"crossref","first-page":"6538","DOI":"10.4049\/jimmunol.0901480","article-title":"A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity","volume":"183","author":"Nochi","year":"2009","journal-title":"J Immunol"},{"issue":"39","key":"10.1016\/j.vaccine.2022.04.051_b0090","doi-asserted-by":"crossref","first-page":"5204","DOI":"10.1016\/j.vaccine.2015.07.074","article-title":"Oral rice-based vaccine induces passive and active immunity against enterotoxigenic E. coli-mediated diarrhea in pigs","volume":"33","author":"Takeyama","year":"2015","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2022.04.051_b0095","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00299-015-1911-9","article-title":"Good manufacturing practices production of a purification-free oral cholera vaccine expressed in transgenic rice plants","volume":"35","author":"Kashima","year":"2016","journal-title":"Plant Cell Rep"},{"key":"10.1016\/j.vaccine.2022.04.051_b0100","doi-asserted-by":"crossref","first-page":"e429","DOI":"10.1016\/S2666-5247(20)30196-8","article-title":"Articles Oral MucoRice-CTB vaccine for safety and microbiota- dependent immunogenicity in humans : a phase 1 randomised trial","volume":"2","author":"Yuki","year":"2021","journal-title":"Lancet Microbe"},{"issue":"5","key":"10.1016\/j.vaccine.2022.04.051_b0105","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/oxfordjournals.jbchem.a134065","article-title":"Mild and efficient conjugation of rabbit fab\u2019 and horseradish peroxidase using a maleimide compound and its use for enzyme immunoassay","volume":"92","author":"Yoshitake","year":"1982","journal-title":"J Biochem"},{"issue":"1","key":"10.1016\/j.vaccine.2022.04.051_b0110","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/bit.1095","article-title":"Production of a recombinant hybrid molecule of cholera toxin-B-subunit and proteolipid-protein-peptide for the treatment of experimental encephalomyelitis","volume":"74","author":"Yuki","year":"2001","journal-title":"Biotechnol Bioeng"},{"issue":"1","key":"10.1016\/j.vaccine.2022.04.051_b0115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/mpat.1994.1007","article-title":"Simple method of purification of Escherichia coli heat-labile enterotoxin and cholera toxin using immobilized galactose","volume":"16","author":"Uesaka","year":"1994","journal-title":"Microb Pathog"},{"issue":"S4","key":"10.1016\/j.vaccine.2022.04.051_b0120","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.vaccine.2022.04.051_b0125","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1128\/iai.65.4.1387-1394.1997","article-title":"Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women","volume":"65","author":"Kozlowski","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2022.04.051_b0130","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1741-7007-8-129","article-title":"Immunogenicity and efficacy of oral vaccines in developing countries: Lessons from a live cholera vaccine","volume":"8","author":"Levine","year":"2010","journal-title":"BMC Biol"},{"issue":"7","key":"10.1016\/j.vaccine.2022.04.051_b0135","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/pbi.12071","article-title":"Induction of toxin-specific neutralizing immunity by molecularly uniform rice-based oral cholera toxin B subunit vaccine without plant-associated sugar modification","volume":"11","author":"Yuki","year":"2013","journal-title":"Plant Biotechnol J"},{"issue":"8","key":"10.1016\/j.vaccine.2022.04.051_b0140","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1007\/s00122-020-03601-4","article-title":"Speed breeding short-day crops by LED-controlled light schemes","volume":"133","author":"J\u00e4hne","year":"2020","journal-title":"Theor Appl Genet"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22004911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22004911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:18:05Z","timestamp":1777537085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22004911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":28,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0264410X22004911"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.04.051","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral MucoRice-CTB vaccine is safe and immunogenic in healthy US adults","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.04.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}